Eric G Carter - Net Worth and Insider Trading

Eric G Carter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric G Carter owns 3 companies in total, including Adverum Biotechnologies Inc (ADVM) , Alder BioPharmaceuticals Inc (ALDR) , and AEON Biopharma Inc (AEON) .

Click here to see the complete history of Eric G Carter’s form 4 insider trades.

Insider Ownership Summary of Eric G Carter

Ticker	Comapny	Transaction Date	Type of Owner
ADVM	Adverum Biotechnologies Inc	2017-09-07	director
ALDR	Alder BioPharmaceuticals Inc	2018-04-23	Interim Chief Medical Officer
AEON	AEON Biopharma Inc	2023-07-21	director

Eric G Carter Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eric G Carter Ownership Network

Ownership Network List of Eric G Carter

No Data

Ownership Network Relation of Eric G Carter

Eric G Carter Owned Company Details

What does Adverum Biotechnologies Inc do?

Who are the key executives at Adverum Biotechnologies Inc?

Eric G Carter is the director of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .

Adverum Biotechnologies Inc (ADVM) Insider Trades Summary

Over the past 18 months, Eric G Carter made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adverum Biotechnologies Inc Insider Transactions

No Available Data

What does Alder BioPharmaceuticals Inc do?

Who are the key executives at Alder BioPharmaceuticals Inc?

Eric G Carter is the Interim Chief Medical Officer of Alder BioPharmaceuticals Inc. Other key executives at Alder BioPharmaceuticals Inc include 10 percent owner H Lundbeck A S , Chief Medical Officer Paul Streck , and director & President and CEO Robert Azelby .

Alder BioPharmaceuticals Inc (ALDR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alder BioPharmaceuticals Inc Insider Transactions

No Available Data

What does AEON Biopharma Inc do?

Who are the key executives at AEON Biopharma Inc?

Eric G Carter is the director of AEON Biopharma Inc. Other key executives at AEON Biopharma Inc include 10 percent owner Strathspey Crown Holdings Group, Llc , director & 10 percent owner Robert J Palmisano , and Chief Financial Officer Peter A Reynolds .

AEON Biopharma Inc (AEON) Insider Trades Summary

Over the past 18 months, Eric G Carter made no insider transaction in AEON Biopharma Inc (AEON). Other recent insider transactions involving AEON Biopharma Inc (AEON) include a net sale of 7,380,394 shares made by Strathspey Crown Holdings Group, Llc ,

In summary, during the past 3 months, insiders sold 0 shares of AEON Biopharma Inc (AEON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,380,394 shares of AEON Biopharma Inc (AEON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,380,394 shares.

AEON Biopharma Inc (AEON)'s detailed insider trading history can be found in Insider Trading Tracker table.

AEON Biopharma Inc Insider Transactions

No Available Data

Eric G Carter Mailing Address

Above is the net worth, insider trading, and ownership report for Eric G Carter. You might contact Eric G Carter via mailing address: C/o King Pharmaceuticals, Inc., 501 Fifth Street, Bristol Tn 37620.

Discussions on Eric G Carter

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.